Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
hypertension
Pharma
George Medicines' combo hypertension prospect posts strong data
With a positive readout for its three-in-one hypertension drug, London-based George Medicines is one step closer to the market.
Fraiser Kansteiner
Aug 31, 2024 4:00am
Idorsia's Tryvio nabs FDA approval following buyback from J&J
Mar 20, 2024 12:40pm
Novartis pays $245M to settle Exforge generic pay-for-delay suit
Jan 3, 2023 11:22am
Alcon is adding 2 more arrows to its opthalmic eye drop quiver
Aug 23, 2022 9:24am
Sanofi pulls hypertension meds in Korea, Canada and the U.K.
Aug 10, 2021 9:14am
Alnylam takes biannual hypertension prospect into phase 2 trial
Jul 6, 2021 7:40am
